Latest Articles
Non-Surgical Approaches to Diagnosing Endometriosis - Pharmaceutical Executive
Non-Surgical Approaches to Diagnosing Endometriosis Pharmaceutical Executive
Published: Dec. 30, 2024, 11:15 a.m.
Proteomics nails near perfect results for endometriosis blood test - Sydney Morning Herald
Proteomics nails near perfect results for endometriosis blood test Sydney Morning Herald
Published: Dec. 30, 2024, 6:04 a.m.
Blood Test Shows Promise for Early Detection of Endometriosis - Head Topics
Blood Test Shows Promise for Early Detection of Endometriosis Head Topics
Published: Dec. 30, 2024, 5:14 a.m.
A novel prognostic score of recurrence for endometrial cancer patients with staging surgery - BioMed Central
A novel prognostic score of recurrence for endometrial cancer patients with staging surgery BioMed Central
Published: Dec. 30, 2024, 4:33 a.m.
A novel prognostic score of recurrence for endometrial cancer patients with staging surgery - bmcwomenshealth.biomedcentral.com
A novel prognostic score of recurrence for endometrial cancer patients with staging surgery bmcwomenshealth.biomedcentral.com
Published: Dec. 30, 2024, 4:33 a.m.
Pfizer faces possible class action after contraceptive Depo-Provera linked to brain tumours - MSN
Pfizer faces possible class action after contraceptive Depo-Provera linked to brain tumours MSN
Published: Dec. 30, 2024, 4:28 a.m.
Telix files for key US approval - Toowoomba Chronicle
Telix files for key US approval Toowoomba Chronicle
Published: Dec. 30, 2024, 12:58 a.m.
Proteomics International Laboratories Ltd (ASX:PIQ) Breakthrough Results for Endometriosis Diagnostic Blood Test - ABN Newswire
Proteomics International Laboratories Ltd (ASX:PIQ) Breakthrough Results for Endometriosis Diagnostic Blood Test ABN Newswire
Published: Dec. 29, 2024, 10:22 p.m.
Proteomics International’s PromarkerEndo Set to Revolutionize Endometriosis Diagnosis - TipRanks
Proteomics International’s PromarkerEndo Set to Revolutionize Endometriosis Diagnosis TipRanks
Published: Dec. 29, 2024, 9:48 p.m.
Pfizer faces possible class action after contraceptive Depo-Provera linked to brain tumours - ABC News
Pfizer faces possible class action after contraceptive Depo-Provera linked to brain tumours ABC News
Published: Dec. 29, 2024, 6:31 p.m.
Link copied to clipboard!